Comparison of Cilostazol and Naftidrofuryl in an Experimental Acute Ischemia-Reperfusion Model.

Ömer Faruk GülaştıŞadan YavuzAli Ahmet ArıkanFatma Ceyla EraldemirErsan ÖzbudakDeniz ŞahinHale Maral Kır

Published in: Vascular and endovascular surgery (2020)

Cilostazol and naftidrofuryl had beneficial effects in all tissues against tissue damage caused by IR injury. In ischemic muscle, kidney and heart cilostazol had improved outcomes comparing to naftidrofuryl. Naftidrofuryl had benefits over cilostazol in liver tissue.

Keyphrases

liver failure
heart failure
oxidative stress
skeletal muscle
respiratory failure
type diabetes
metabolic syndrome
ischemia reperfusion injury
adipose tissue
hepatitis b virus
blood brain barrier
clinical evaluation
mechanical ventilation